Literature DB >> 8114619

Sulfated glycoprotein-2 mRNA in the rat brain following transient forebrain ischemia.

C Wiessner1, T Back, P Bonnekoh, K Kohno, J Gehrmann, K A Hossmann.   

Abstract

Expression of sulfated glycoprotein-2 (SGP-2) mRNA was studied by in situ hybridization in rat brains submitted to transient forebrain ischemia of 30 min. Induction of this multifunctional protein has been previously observed following diverse types of brain lesions, and an involvement in programmed cell death and synaptic remodelling has been proposed. Ischemia was produced by four-vessel occlusion and followed by various recirculation times ranging from 15 min to 7 days. Up to 6 h after ischemia SGP-2 mRNA did not change in any brain region. After 12 h recirculation, SGP-2 mRNA induction was observed in the stratum lacunosum moleculare of CA1 sector of hippocampus. This induction peaked at 3 days recirculation and then declined. From 24 h recirculation onward, induction also occurred in patchy areas of the cortex, and after 7 days recirculation in the ventral thalamus and in a corona around lesioned parts of the striatum. No induction occurred at any recirculation time in pyramidal neurons of hippocampus or other neuronal populations that are damaged by ischemia. The combination of in situ hybridization with GFAP immunohistochemistry revealed that SGP-2 mRNA was mainly induced in reactive actrocytes. This excludes a direct involvement in ischemic neuronal death and supports the possible participation in the post-lesional reorganization of the tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8114619     DOI: 10.1016/0169-328x(93)90061-s

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  1 in total

1.  Protein synthesis and energy metabolism in hippocampal slices during extended (24 hours) recovery following different periods of ischemia.

Authors:  B Djuricic; R Berger; W Paschen
Journal:  Metab Brain Dis       Date:  1994-12       Impact factor: 3.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.